The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.
暂无分享，去创建一个
S. Pittaluga | T. Fojo | A. Venkatesan | Sherry X. Yang | S. Balasubramaniam | C. O'Sullivan | J. Wilkerson | M. Edgerly | D. Nguyen | M. Velarde